Doctor profile · Federal record
Dr. Jo-Ann Szylit, MD
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Kinnelon, NJ
- NPI 1134102106
- Accepts Medicare
- MIPS 98.4 / 100 · 2023
- 48 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
135 Kinnelon RD, Suite 103
Kinnelon, NJ 074052333
(973) 838-1771
fax (973) 492-2858
Credentials & registration
- NPI registered
- November 2005 — 21 yrs on file
- Profile last updated
- April 29, 2021
- Year of graduation
- 1978 — 48 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- New Jersey #25MA04598300 · New York #139-353
- Medicaid
- NJ #0566900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1134102106. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,412
Distinct HCPCS
10
Medicare allowed
$454,655
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,947 | 1,471 | $101 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,196 | 296 | $8 | |
11102 |
Biopsy of related skin growth, first growth | 675 | 581 | $114 | |
17000 |
Destruction of precancer skin growth, 1 growth | 573 | 475 | $72 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 292 | 260 | $143 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 231 | 231 | $122 | |
11103 |
Biopsy of related skin growth, each additional growth | 180 | 136 | $59 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 65 | 60 | $52 | |
17110 |
Destruction of skin growth, 1-14 growths | 54 | 47 | $132 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 47 | 44 | $207 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 338. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$705
Transactions
44
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 18 | $172.34 | |
| Janssen Biotech, Inc. | 1 | $94.99 | |
| Novartis Pharmaceuticals Corporation | 4 | $85.67 | |
| GENZYME CORPORATION | 4 | $74.96 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $65.37 | |
| Arcutis Biotherapeutics, Inc. | 4 | $63.22 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $49.09 | |
| Amgen Inc. | 2 | $34.80 | |
| LEO Pharma Inc. | 1 | $17.39 | |
| Galderma Laboratories, L.P. | 1 | $16.72 | |
| PFIZER INC. | 1 | $15.78 | |
| Dermavant Sciences, Inc. | 1 | $14.84 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
905
Patients
624
Total drug cost
$89,596
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 165 | 114 | $1,449 |
| Fluocinonide | Generic | 137 | 101 | $5,945 |
| Ketoconazole | Generic | 100 | 61 | $2,421 |
| Fluticasone Propionate | Generic | 72 | 52 | $998 |
| Metronidazole | Generic | 68 | 47 | $2,750 |
| Mometasone Furoate | Generic | 56 | 47 | $1,283 |
| Doxycycline Hyclate | Generic | 55 | 21 | $1,105 |
| Mupirocin | Generic | 51 | 47 | $435 |
| Fluorouracil | Generic | 43 | 41 | $2,775 |
| Clobetasol Propionate | Generic | 39 | 22 | $2,507 |
Frequently asked questions
What is Dr. Jo-Ann Szylit's medical specialty?
Dr. Jo-Ann Szylit practices Dermatology Physician in Kinnelon, NJ.
Where does Dr. Jo-Ann Szylit practice?
Dr. Jo-Ann Szylit practices at 135 Kinnelon RD, Kinnelon, NJ 074052333. Office phone: 9738381771.
What is Dr. Jo-Ann Szylit's NPI?
Dr. Jo-Ann Szylit's National Provider Identifier (NPI) is 1134102106, issued by NPPES.
Does Dr. Jo-Ann Szylit accept Medicare assignment?
Yes. Dr. Jo-Ann Szylit accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jo-Ann Szylit commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Biopsy of related skin growth, first growth (HCPCS 11102). Source: CMS Medicare Physician & Other Practitioners file.